Total Reports
104
FDA CVM filings
Cat /
FDA CVM · 2025 release 104 reports on file
Bombay - FDA Adverse Event Profile
Adverse-event records for Bombay (Cat) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Bombay ranks #227 by report volume among cat breeds - 9 of 104 reports (8.7%) recorded a death outcome.
- #227
- most-reported cat breed
- 8.7%
- death-coded report share
- 16
- Application site hair loss - top reaction
- 7.5 yr
- average age at report
Report counts track breed popularity and reporting activity, not real-world risk, read this alongside how common the breed is.
Deaths Reported
9
of 104 reports
Death Rate
8.7%
death-coded share
Avg Age at Report
7.5 yr
5.5 kg avg weight
Death-Coded Outcome Share
Bombay death-coded reports 8.7%
Cross-breed median
8.7% of 104 bombay reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 5.5 kg (12.1 lbs)
Top Reported Reactions
Application site hair loss 16
Vomiting 16
Lethargy (see also Central nervous system depression in 'Neurological') 9
Lack of efficacy (ectoparasite) - flea 9
Anorexia 8
Behavioural disorder NOS 7
Application site alopecia 7
Not eating 7
Most Referenced Drugs
Fluralaner Spot-On Solution 16
Selamectin;Sarolaner 13
Spinosad 12
Frunevetmab 12
Nitenpyram 9
Buprenorphine 7
Selamectin 6
Maropitant Citrate 6
Outcome Breakdown
Ongoing
37 (35.6%)
Outcome Unknown
35 (33.7%)
Recovered/Normal
22 (21.2%)
Euthanized
5 (4.8%)
Died
4 (3.8%)
Recovered with Sequela
1 (1.0%)
Gender Distribution
Male 64 (61.5%)
Female 38 (36.5%)
Unknown 2 (1.9%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2012 | 4 | |
| 2013 | 4 | |
| 2014 | 2 | |
| 2015 | 3 | |
| 2016 | 7 | |
| 2017 | 5 | |
| 2018 | 9 | |
| 2019 | 4 | |
| 2020 | 5 | |
| 2021 | 11 | |
| 2022 | 3 | |
| 2023 | 13 | |
| 2024 | 21 | |
| 2025 | 13 | |
Bombay Pet Health Insights
Bombay accounts for 104 FDA adverse event reports, ranking #227 by volume among cat breeds, with 9 reports (8.7%) coded as a death outcome. Mean age at report: 7.5 years, average weight 5.5 kg (12.1 lbs).
Top reported signs: Application site hair loss (16), Vomiting (16), Lethargy (see also Central nervous system depression in 'Neurological') (9). Most-referenced drug: Fluralaner Spot-On Solution (16 reports), followed by Selamectin;Sarolaner (13) and Spinosad (12).
Outcome coding on 104 status-recorded reports is dominated by Ongoing (35.6%). Annual submissions ranged 2,012-2,025 across 14 years on file.
Cat Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Bombay? ▼
There are 104 adverse event reports involving Bombay in the FDA database, with 9 reports involving death (8.7% death rate). Bombay ranks #227 by report volume.
What are the most common adverse reactions reported for Bombay? ▼
The most commonly reported adverse reactions for Bombay are Application site hair loss (16 reports), Vomiting (16 reports), Lethargy (see also Central nervous system depression in 'Neurological') (9 reports), Lack of efficacy (ectoparasite) - flea (9 reports), Anorexia (8 reports).
What drugs are most frequently associated with Bombay adverse events? ▼
The drugs most frequently referenced in Bombay adverse event reports are Fluralaner Spot-On Solution (16 reports), Selamectin;Sarolaner (13 reports), Spinosad (12 reports), Frunevetmab (12 reports), Nitenpyram (9 reports).
What is the average age of Bombay in adverse event reports? ▼
The average age of Bombay at the time of adverse event reports is 7.5 years, with an average weight of 5.5 kg (12.1 lbs).
Does a high number of adverse event reports mean Bombay is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Bombay safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.